Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

914.57 +16.47 (+1.83%)
Official Closing Price Updated: 7:00 PM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,880,865
Open 898.42
Bid (Size) 909.00 (5)
Ask (Size) 916.45 (1)
Prev. Close 898.10
Today's Range 896.90 - 916.46
52wk Range 434.34 - 918.50
Shares Outstanding N/A
Dividend Yield 0.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The 7 Best Under $10 Stocks to Buy in July 2024
We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now. 
Via InvestorPlace
Copper, Gold Stocks Sparkle, Among 5 Leaders Near Buy Points
Southern Copper and Agnico Eagle surged above early entries. 
Via Investor's Business Daily

Performance

YTD
+54.44%
+54.44%
1 Month
+9.23%
+9.23%
3 Month
+17.66%
+17.66%
6 Month
+46.09%
+46.09%
1 Year
+102.30%
+102.30%

More News

Read More
What's Going On With Eli Lilly Shares Friday?
Via Benzinga
GLP-1 Treatments Such As Wegvoy, Mounjaro Cut Obesity-Related Cancer Risks, Study Finds
Via Benzinga
Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Smart Money Is Betting Big In LLY Options
Via Benzinga
Here's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
Via Benzinga
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
Via Investor's Business Daily
Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
Via The Motley Fool
3 Highly Rated Biotech Stocks for Your July Buy List
Via InvestorPlace
7 High Priced Stocks That Would Benefit From a Stock Split
Via InvestorPlace
Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
Via The Motley Fool
The 3 Best Healthcare Stocks to Buy in July 2024
Via InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
Via The Motley Fool
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
Via Investor's Business Daily
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
Via Benzinga
Exposures Product Safety
'Other Bets' Startup Mineral Bites The Dust In Google Cost Cutting Move
Via Investor's Business Daily
Top 3 Health Care Stocks That May Crash This Quarter
Via Benzinga
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
Via MarketBeat
Exposures Product Safety
These 4 Vanguard ETFs Soared Over 20% in the First Half of 2024. Here's Which One Is Most Likely to Fly Even Higher.
Via The Motley Fool
Topics ETFs
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Via Benzinga
Exposures Product Safety
Eli Lilly Receives FDA Approval For Its Alzheimer’s Drug Kinsula
Via Talk Markets
Exposures Product Safety
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
AMZN Stock Outlook: Amazon’s Next Growth Wave Could Make Early Investors Rich
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.